company

HURDAL APOTEK AS

2090 HURDAL

Return on Equity
−11,9 %
Current Ratio
1,54
Debt-to-Equity Ratio
2,07
Key figures (NOK)2022
Revenue2 483 000
Net Income−84 000
Total Assets4 135 000
Total Equity706 000
Income (NOK)2022
Revenue2 483 000
Expenditure2 554 000
Operating Profit−71 000
Financial Income0
Financial Costs14 000
Financial Balance−14 000
Earnings Before Tax−84 000
Tax0
Net Income−84 000
Balance (NOK)2022
Total Fixed Assets1 103 000
Total Current Assets3 032 000
Total Assets4 135 000
Total Retained Equity−84 000
Total Equity706 000
Total Long-Term Debt1 464 000
Total Current Debt1 965 000
Total Equity and Debt4 135 000
Cash flow (NOK)2022
Sales Income2 483 000
Other Income0
Revenue2 483 000
Cost of Goods Sold1 809 000
Salary Costs432 000
Depreciation28 000
Impairment0
Expenditure2 554 000
Operating Profit−71 000
Financial Income0
Financial Costs14 000
Financial Balance−14 000
Dividends0
Net Income−84 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures1 103 000
Total Tangible Assets1 103 000
Total Fiancial Fixed Assets0
Total Fixed Assets1 103 000
Stock1 277 000
Total Investments0
Cash, Bank1 355 000
Total Current Assets3 032 000
Total Assets4 135 000
Total Equity706 000
Short-Term Group Debt0
Total Long-Term Debt1 464 000
Creditors1 680 000
Unpaid Taxes231 000
Dividends0
Other Current Debt54 000
Total Current Debt1 965 000
Total Equity and Debt4 135 000
Financial indicators2022
Return on Equity−11,9 %
Debt-to-Equity Ratio2,07
Operating Profit Margin−2,86 %
Current Ratio1,54
Quick Ratio4,41
Equity Ratio0,17
Gross Profit Margin27,14 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English